Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036705592> ?p ?o ?g. }
- W3036705592 endingPage "1070" @default.
- W3036705592 startingPage "1055" @default.
- W3036705592 abstract "In the drive towards faster patient access to treatments, health technology assessment (HTA) agencies are increasingly faced with reliance on evidence from surrogate endpoints, leading to increased decision uncertainty. This study undertook an updated survey of methodological guidance for using surrogate endpoints across international HTA agencies. We reviewed HTA and economic evaluation methods guidance from European, Australian and Canadian HTA agencies. We considered how guidelines addressed the methods for handling surrogate endpoints, including (1) level of evidence, (2) methods of validation, and (3) thresholds of acceptability. Across the 73 HTA agencies surveyed, 29 (40%) had methodological guidelines that made specific reference to consideration of surrogate outcomes. Of the 45 methods documents analysed, the majority [27 (60%)] were non-technology specific, 15 (33%) focused on pharmaceuticals and three (7%) on medical devices. The principles of the European network for Health Technology Assessment (EUnetHTA) guidelines published in 2015 on the handling of surrogate endpoints appear to have been adopted by many European HTA agencies, i.e. preference for final patient-relevant outcomes and reliance on surrogate endpoints with biological plausibility and epidemiological evidence of the association between the surrogate and final endpoint. Only a small number of HTA agencies (UK National Institute for Care and Excellence; the German Institute for Medical Documentation and Information and Institute for Quality and Efficiency in Health Care; the Australian Pharmaceutical Benefits Advisory Committee; and the Canadian Agency for Drugs and Technologies in Health) have developed more detailed prescriptive criteria for the acceptance of surrogate endpoints, e.g. meta-analyses of randomised controlled trials showing strong association between the treatment effect on the surrogate and final outcomes. As the decision uncertainty associated with reliance on surrogate endpoints carries a risk to patients and society, there is a need for HTA agencies to develop more detailed methodological guidance for consistent selection and evaluation of health technologies that lack definitive final patient-relevant outcome evidence at the time of the assessment." @default.
- W3036705592 created "2020-06-25" @default.
- W3036705592 creator A5003818016 @default.
- W3036705592 creator A5008052793 @default.
- W3036705592 creator A5008305485 @default.
- W3036705592 creator A5024183775 @default.
- W3036705592 creator A5033435116 @default.
- W3036705592 creator A5039851179 @default.
- W3036705592 creator A5053258579 @default.
- W3036705592 creator A5070523155 @default.
- W3036705592 creator A5084898316 @default.
- W3036705592 creator A5086670917 @default.
- W3036705592 date "2020-06-23" @default.
- W3036705592 modified "2023-10-17" @default.
- W3036705592 title "Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines" @default.
- W3036705592 cites W1558155053 @default.
- W3036705592 cites W1964720544 @default.
- W3036705592 cites W1985046983 @default.
- W3036705592 cites W2003871702 @default.
- W3036705592 cites W2014781078 @default.
- W3036705592 cites W2021046234 @default.
- W3036705592 cites W2021135937 @default.
- W3036705592 cites W2072684436 @default.
- W3036705592 cites W2080675410 @default.
- W3036705592 cites W2126426045 @default.
- W3036705592 cites W2132337993 @default.
- W3036705592 cites W2140922502 @default.
- W3036705592 cites W2145611811 @default.
- W3036705592 cites W2159953548 @default.
- W3036705592 cites W2164180552 @default.
- W3036705592 cites W2170097076 @default.
- W3036705592 cites W2508307252 @default.
- W3036705592 cites W2562521254 @default.
- W3036705592 cites W2583529806 @default.
- W3036705592 cites W2733307304 @default.
- W3036705592 cites W2766589848 @default.
- W3036705592 cites W2793539832 @default.
- W3036705592 cites W2806964480 @default.
- W3036705592 cites W28497082 @default.
- W3036705592 cites W3017195870 @default.
- W3036705592 doi "https://doi.org/10.1007/s40273-020-00935-1" @default.
- W3036705592 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32572825" @default.
- W3036705592 hasPublicationYear "2020" @default.
- W3036705592 type Work @default.
- W3036705592 sameAs 3036705592 @default.
- W3036705592 citedByCount "29" @default.
- W3036705592 countsByYear W30367055922020 @default.
- W3036705592 countsByYear W30367055922021 @default.
- W3036705592 countsByYear W30367055922022 @default.
- W3036705592 countsByYear W30367055922023 @default.
- W3036705592 crossrefType "journal-article" @default.
- W3036705592 hasAuthorship W3036705592A5003818016 @default.
- W3036705592 hasAuthorship W3036705592A5008052793 @default.
- W3036705592 hasAuthorship W3036705592A5008305485 @default.
- W3036705592 hasAuthorship W3036705592A5024183775 @default.
- W3036705592 hasAuthorship W3036705592A5033435116 @default.
- W3036705592 hasAuthorship W3036705592A5039851179 @default.
- W3036705592 hasAuthorship W3036705592A5053258579 @default.
- W3036705592 hasAuthorship W3036705592A5070523155 @default.
- W3036705592 hasAuthorship W3036705592A5084898316 @default.
- W3036705592 hasAuthorship W3036705592A5086670917 @default.
- W3036705592 hasBestOaLocation W30367055921 @default.
- W3036705592 hasConcept C108170787 @default.
- W3036705592 hasConcept C111472728 @default.
- W3036705592 hasConcept C126838900 @default.
- W3036705592 hasConcept C138816342 @default.
- W3036705592 hasConcept C138885662 @default.
- W3036705592 hasConcept C141341695 @default.
- W3036705592 hasConcept C142724271 @default.
- W3036705592 hasConcept C159110408 @default.
- W3036705592 hasConcept C160735492 @default.
- W3036705592 hasConcept C17744445 @default.
- W3036705592 hasConcept C177713679 @default.
- W3036705592 hasConcept C199360897 @default.
- W3036705592 hasConcept C199539241 @default.
- W3036705592 hasConcept C21333345 @default.
- W3036705592 hasConcept C2776125615 @default.
- W3036705592 hasConcept C2776738588 @default.
- W3036705592 hasConcept C2777352838 @default.
- W3036705592 hasConcept C41008148 @default.
- W3036705592 hasConcept C524218345 @default.
- W3036705592 hasConcept C56666940 @default.
- W3036705592 hasConcept C71924100 @default.
- W3036705592 hasConceptScore W3036705592C108170787 @default.
- W3036705592 hasConceptScore W3036705592C111472728 @default.
- W3036705592 hasConceptScore W3036705592C126838900 @default.
- W3036705592 hasConceptScore W3036705592C138816342 @default.
- W3036705592 hasConceptScore W3036705592C138885662 @default.
- W3036705592 hasConceptScore W3036705592C141341695 @default.
- W3036705592 hasConceptScore W3036705592C142724271 @default.
- W3036705592 hasConceptScore W3036705592C159110408 @default.
- W3036705592 hasConceptScore W3036705592C160735492 @default.
- W3036705592 hasConceptScore W3036705592C17744445 @default.
- W3036705592 hasConceptScore W3036705592C177713679 @default.
- W3036705592 hasConceptScore W3036705592C199360897 @default.
- W3036705592 hasConceptScore W3036705592C199539241 @default.
- W3036705592 hasConceptScore W3036705592C21333345 @default.
- W3036705592 hasConceptScore W3036705592C2776125615 @default.